FREQUENCY OF VITAMIN D DEFICIENCY IN PREMATURE NEWBORN BORN BEFORE 32 WEEKS AND/OR WITH A BIRTH WEIGHT UNDER 1500g
NCT ID: NCT06315452
Last Updated: 2024-03-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
110 participants
OBSERVATIONAL
2022-02-01
2024-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this study was to determine the frequency of vitamin D deficiency in premature newborns.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Respiratory Outcomes After Early Vitamin D Supplementation in Infants Born Extremely Preterm
NCT05615311
Wheezing in Black Preterm Infants: Impact of Vitamin D Supplementation Strategy
NCT01601847
Prebiotic in Preterm Infants
NCT03306316
Early Nutrition and Neurological Development of Very Preterm Infants
NCT01486173
Metabolic Effects of Choline and Docosahexaenoic Acid Supplementation in Preterm Infants
NCT02509728
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having received at least one dosage of 25 OH vitamin D.-
Exclusion Criteria
1 Day
6 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fondation Hôpital Saint-Joseph
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital Saint Joseph
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PremaVitaD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.